PSAT1 and nonpapillary renal cell carcinoma: PSAT1, involved in serine metabolism, is overexpressed in advanced ccRCC and correlates with poor prognosis, its inhibition increases sunitinib sensitivity, particularly in treatment-resistant cases (49, 50).